A Proof-of-Concept, Randomized, Double Blind, Placebo and Active Control, 3-Period, Crossover Design Study Assessing NEO6860 in Patients With Pain Associated With Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs NEO 6860 (Primary) ; Naproxen
- Indications Pain
- Focus Proof of concept; Therapeutic Use
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 20 Sep 2017 According to a NEOMED Institute media release, results from this trial will be presented at the Pain & Migraine Therapeutic Summit.
- 10 Mar 2017 Status changed from recruiting to completed.